Pharmacy Clinical Guidelines
The following criteria have changes going into effect on March 2, 2026:
- Bavencio
- bendamustine Products
- Blenrep SGM
- Gamifant
- Gazyva SGM
- Iclusig
- Inlyta
- Kerendia (retiring)
- Keytruda
- Komzifti SGM
- Kygevvi SGM
- Leuprolide
- Onpattro
- Padcev
- pazopanib-Votrient
- Scemblix
- sorafenib-Nexavar
- sunitinib-Sutent
- Tecentriq Hybreza SGM
- Tecentriq SGM
- Tegsedi
- temsirolimus-Torisel
- Wainua
- Welireg
- Zepzelca
- Ztalmy
The following criteria have changes going into effect on May 1, 2026:
- Akeega (niraparid and abiraterone acetate)
- Arzerra (ofatumumab)
- Besponsa (inotuzumab ozogamicin)
- Blincyto (blinatumomab)
- Cometriq (cabozantinib)
- Elrexfio (elranatamab-bcmm)
- Firdapse (mifampridine)
- Gazyva (obinutuzumab)
- Imbruvica (ibrutinib)
- Imfinzi (durvalumab)
- Imjudo (tremelimumab-actl)
- Lenvima (lenvatinib)
- Leukine (sargramostim)
- Lorbrena (lorlatinib)
- Lunsumio (mosunetuzumab-axgb)
- Lynparza (olaparib)
- Neulasta and Pegfilgrastim Biosimilars
- Neupogen and Filgrastim Biosimilars
- Nplate (romiplostim)
- Promacta - Alvaiz (eltrombobag olamin/choline)
- Pyrukynd (mitapivat)
- Reblozyl (luspatercept-ammt)
- Revuforj (revumenib)
- Rolvedon (eflapegrastim-xnst)
- Ryzneuta (efbemalenograstim alfa-vuxw)
- Stivarga (regorafenib)
- Strontium Chloride Sr-89 (Metastron)
- Talvey (talquetamab-tgvs)
- Talzenna (talazoparib)
- Tecvayli (teclistamab-cqyv)
- Voranigo (vorasidenib)
- Xeloda (capecitabine)
- Zytiga (abiraterone)
The following criteria have changes going into effect on June 1, 2026:
Choose a tab to select Pharmacy Clinical Guidelines or Exceptions
Pharmacy Clinical Guidelines
Select the starting letter of the medication or condition to find the desired form.
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Exceptions
Select the starting letter of the medication or condition to find the desired form.
View Oscar's Custom Exceptions Criteria for Autoimmune Conditions